Table 1.
PLC | DEX | PROP | ||||
---|---|---|---|---|---|---|
Men | Women | Men | Women | Men | Women | |
TMD | 104 (189) | 91.8 (265) | 91.9 (79.4) | 271 (255) | 96.1 (227) | 261 (323) |
Anxiety | 69.5 (58.3) | 118 (94.1) | 88.5 (88.4) | 150 (75.1) | 99.5 (86.5) | 109 (122) |
Depression | −11.6 (44.4) | 33.3 (73.5) | −26.3 (32.1) | 28.1 (45.8) | 3.46 (29.3) | 37.8 (78.3) |
Anger | 2.72 (29.5) | −11.1 (39.5) | −27.8 (40.1) | 36.2 (34.6) | −10.9 (51.2) | 26.5 (46.9) |
VAS | 34.5 (29.1) | 49.4 (41.8) | 37.9 (27.9) | 85 (46.7) | 51.8 (31) | 61.7 (53) |
Mean and standard deviations (in parentheses) for AUCs of mood and subjective-stress measures across drug conditions in men and women.
PLC placebo condition (no suppression), DEX dexamethasone (HPA suppression), PROP propranolol (SNS suppression), TMD total mood disturbance, VAS visual analog scale.